Evidence map›Paper›PMID 40880197›Full record

ArticleJournal of the American Society of Nephrology : JASN2026

Pyruvate Dehydrogenase and Cellular Metabolism in Calcineurin Inhibitor-Induced Kidney Fibrosis.

Yasuhiro Oda, Hiroshi Nishi, Fumie Hamano, Teruhiko Yoshida, Yoshihiro Kita, Jeffrey B Kopp, Masaomi Nangaku

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Yasuhiro OdaDivision of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.ORCID 0000-0002-7043-7676
Hiroshi NishiDivision of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Fumie HamanoLife Sciences Core Facility, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.ORCID 0009-0003-0746-158
Teruhiko YoshidaKidney Disease Section, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.ORCID 0000-0002-2049-7347
Yoshihiro KitaLife Sciences Core Facility, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.ORCID 0000-0001-7377-5956
Jeffrey B KoppKidney Disease Section, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.ORCID 0000-0001-9052-186
Masaomi NangakuDivision of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.ORCID 0000-0001-7401-2934

Funding

Japan Science and Technology Agency JPMJSP2108Japan Society for the Promotion of Science 23H02924Japan Society for the Promotion of Science 23KJ0437Japan Society for the Promotion of Science 24K11425Japan Society for the Promotion of Science 25K19483
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CKDcyclosporine nephrotoxicitydrug nephrotoxicityfibrosismetabolismmitochondriamolecular biologyproximal tubuletacrolimustranscriptional profiling

Identifiers

PMID40880197
PMCPMC12935326

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.